Immunovant (IMVT) Proxy Filing summary

Voting matters and shareholder proposals

• Election of three directors to serve until the 2026 Annual Meeting and until successors are elected and qualified.

• Ratification of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending March 31, 2026.

• Advisory vote to approve compensation of named executive officers.

• Proxy holders authorized to vote on other business arising at the meeting.

Board of directors and corporate governance

• Three director nominees: Jacob Bauer, Douglas Hughes, and Robert Susman.

• Directors to serve until the 2026 Annual Meeting and until successors are qualified.

Executive compensation and say-on-pay

• Advisory, non-binding vote on the compensation of named executive officers is included as a proposal.